Valuation : Novartis AG

Market Cap 263B 226B 213B 194B 363B 25,114B 366B 2,538B 977B 12,738B 986B 965B 40,461B P/E 2026 *
19.5x
P/E 2027 * 16.7x
Enterprise Value 294B 253B 239B 218B 407B 28,134B 410B 2,844B 1,094B 14,270B 1,105B 1,081B 45,325B EV / Sales 2026 *
5.11x
EV / Sales 2027 * 4.74x
Free-Float
91.66%
Yield 2026 *
3.19%
Yield 2027 * 3.33%
1 day-0.36%
1 week-14.66%
Current month-8.19%
1 month-10.84%
3 months-6.80%
6 months-11.01%
Current year+1.86%
1 week 117.76
Extreme 117.76
134.98
1 month 117.76
Extreme 117.76
141.08
Current year 116.64
Extreme 116.64
143.52
1 year 103.18
Extreme 103.18
143.52
3 years 94.21
Extreme 94.21
143.52
5 years 94.21
Extreme 94.21
143.52
10 years 94.21
Extreme 94.21
143.52
Manager TitleAgeSince
Chief Executive Officer 50 2018-01-31
Director of Finance/CFO - 2026-03-15
Compliance Officer 58 2025-04-13
Director TitleAgeSince
Director/Board Member 67 2014-12-31
Director/Board Member 69 2015-12-31
Director/Board Member 61 2015-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-0.39%-14.66% - - 263B
-0.11%-3.16%+48.82%+91.49% 1,001B
-0.27%-4.34%+51.52%+65.89% 642B
+1.63%-2.00%+20.49%+71.12% 451B
+0.48%-2.77%+29.32%+36.71% 340B
+1.07%-12.56%+11.32%+28.30% 263B
+0.72%-1.42%-1.00%+12.70% 247B
-2.25%-13.88%+37.33%+47.43% 207B
-2.14%-6.27%-19.01%-59.04% 197B
-0.58%-4.24%+25.65%+90.54% 180B
Average -0.12%-5.53%+22.71%+42.79% 391.82B
Weighted average by Cap. +0.11%-4.65%+31.89%+57.68%

Financials

2026 *2027 *
Net sales 57.64B 49.57B 46.77B 42.61B 79.65B 5,511B 80.37B 557B 214B 2,795B 216B 212B 8,878B 61.32B 52.73B 49.76B 45.33B 84.73B 5,863B 85.5B 593B 228B 2,974B 230B 225B 9,445B
Net income 14.19B 12.2B 11.51B 10.49B 19.61B 1,357B 19.79B 137B 52.78B 688B 53.29B 52.12B 2,186B 15.75B 13.54B 12.78B 11.64B 21.76B 1,506B 21.96B 152B 58.57B 764B 59.14B 57.84B 2,426B
Net Debt 31.58B 27.16B 25.63B 23.35B 43.64B 3,020B 44.04B 305B 117B 1,532B 119B 116B 4,865B 27.9B 23.99B 22.64B 20.62B 38.55B 2,667B 38.9B 270B 104B 1,353B 105B 102B 4,297B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change
26-09-07 120.40 -10.80%
26-09-10 €119.48 +0.50%
26-09-09 €118.88 -1.26%
26-09-08 €120.40 -10.80%
26-09-07 €134.98 -2.23%
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
23
Last Close Price
138.20USD
Average target price
154.17USD
Spread / Average Target
+11.56%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!